University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

Dendritic cell therapy has emerged as a promising alternative for treating various forms of cancer, particularly in ...

UVA Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

Immunotherapies use the body's own immune system to fight cancer cells. Plasmacytoid dendritic cells (pDCs), which are activated by Imiquimod via TLR7/8, play an important role in this process. The ...

Effective for local tumors and distant metastases Immunotherapies use the body's own immune system to fight cancer cells. Plasmacytoid dendritic cells (pDCs), which are activated by Imiquimod via TLR7 ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...

Priming and sustaining robust T-cell responses require antigen presenting cells (APCs), particularly dendritic cells (DCs). Thus, APC- or DC-based vaccines and related therapeutic strategies against ...

Suppression of antitumor immune ... tumor cells escape from destruction by the immune system. Myeloid-derived suppressor cells (MDSCs) represent the main immunosuppressive cells present in the tumor ...